Analjit Singh appointed non-executive Chairman of Max Financial Services

New Delhi: Max Financial Services, which houses the life insurance business of the $3-billion Max Group, has named its sponsor and founding shareholder Analjit Singh as nonexecutive chairman of the company in a filing to stock exchanges on Monday.

Singh said his appointment on the board was in consultation with current chairman Naina Lal Kidwai, who felt that as the ‘principal sponsor’ of the company he would be able to expedite decision-making. Kidwai will now continue in her role as an independent non-executive director of the company.

“I am heavily committed to India, to my businesses and my family,” Singh told ET, refuting what he termed ‘rhetoric’ about him giving up on his home turf.

The Max Group founder also ruled out speculation pertaining to his plans to exit the life insurance venture. “We are not going to exit the business. I will remain the single-largest principal sponsor,” he said.

Singh will take a four-point plan to the board of the financial services company on Friday to strengthen the life insurance business with a focus on building its proprietary distribution channels, he told ET.

Max Life Insurance Company is the largest non-bank private life insurer in India and contributes over two-thirds of Max Group’s revenues.

The company was separated as part of a demerger process involving erstwhile Max India, following which it became a subsidiary of the listed Max Financial Services.

Max India and Max Ventures and Industries are two other listed entities that resulted from the demerger. The former houses the group’s hospitals business and its health insurance joint venture with Britain’s Bupa, while the latter is the holding company for the packaging and real estate interests of the group.

Japan’s Mitsui Sumitomo Insurance is an investor in Max Life Insurance Company.

The group recorded consolidated revenues of Rs 19,151 crore in the year to March 2018, the company stated in its exchange filings. It employs 24,500 people.

  • Related Posts

    Yashoda Medicity lifts Benchmark in Critical Care to New High

    With the introduction of North India’s first Advanced VitalGo Total Lift Bed Technology Ghaziabad/ New Delhi: In an ideal hospital, critical care is most paramount and it is also the…

    A ‘Fatal Flaw’ might be lurking in apparently Healthy Heart- Dr Devi Shetty

    Healthy Heart is a Misnomer until underpinned by Regular Screening Bangaluru/ New Delhi: Of late, heart health has become kind of a veritable conundrum. We were never so unsure of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Nearly Three in Ten Products in Indian Local Markets Perceived as Counterfeit; Pharmaceuticals and FMCG among Worst-Affected Sectors: ASPA–CRISIL Intelligence Report

    Nearly Three in Ten Products in Indian Local Markets Perceived as Counterfeit; Pharmaceuticals and FMCG among Worst-Affected Sectors: ASPA–CRISIL Intelligence Report

    Culture reports reveal bacteria damaged cornea of five patients from Kuchaman

    Culture reports reveal bacteria damaged cornea of five patients from Kuchaman

    FSSAI prohibits Dabur from selling food products with ‘100%’ claims

    FSSAI prohibits Dabur from selling food products with ‘100%’ claims

    ORSL reinforces its commitment to improve diarrhoeal prevention in children

    ORSL reinforces its commitment to improve diarrhoeal prevention in children

    ‘Donors got mixer grinders, cash’: blood banks in Bengal under scanner over ‘illegal’ sale to other States

    ‘Donors got mixer grinders, cash’: blood banks in Bengal under scanner over ‘illegal’ sale to other States

    CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University

    CREATE Medicines expands targeted in vivo CAR platform through strategic research collaboration and exclusive license pact with Monash University